Self-management for People With Epilepsy and a History of Negative Health Events

Epilepsy Clinical Trial

— SMART  

Official title:

Self-management for People With Epilepsy and a History of Negative Health Events (SMART)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02970396
• Other study ID #: 12-14-07
• Status: Completed
• Phase: N/A
• Start date: September 2014
• Est. completion date: December 2018

Study information

• Verified date: December 2018
• Source: Case Western Reserve University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is an investigation of adult individuals with epilepsy, and involves educational and behavioral interventions intended to enhance treatment adherence and self-management.

The investigators are adapting a self-management intervention that they developed in a previous study to individuals with epilepsy and a history of negative health events (NHEs), such as accidents and emergency department (ED) visits, diminished quality of life and poor mental well-being. The intervention "Self-management for people with epilepsy and a history of negative health events (SMART)" is intended to reduce NHEs and improve quality of life in people with epilepsy associated with historically disadvantaged groups.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 121
• Est. completion date: December 2018
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Diagnosis of epilepsy

• Negative health event within the last 6 months

• Able to provide written consent and participate in study procedures

Exclusion Criteria:

• Immediate risk of self-harm

• Dementia

• Pregnancy

• Unable to read/understand English

Related Conditions & MeSH terms

• Epilepsy

Intervention

Behavioral:
• self-management

Locations

Country	Name	City	State
United States	Case Western Reserve University	Cleveland	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Case Western Reserve University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in number of negative health events		baseline, 6 months